{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/03/26/3263104/0/en/Rhythm-Pharmaceuticals-Receives-Positive-CHMP-Opinion-for-IMCIVREE-setmelanotide-for-the-Treatment-of-Obesity-and-Control-of-Hunger-in-Patients-with-Acquired-Hypothalamic-Obesity-d.html", "message": "News view counter 625506 successfully enlarged"}